›US diverts vaccination raw material orders to Serum Institute, to send CDC team to help India fight Covid
US diverts vaccination raw material orders to Serum Institute, to send CDC team to help India fight Covid
SECTIONS
US diverts vaccination raw material orders to Serum Institute, to send CDC team to help India fight CovidBy
Share
Synopsis
Besides, top American companies have formed a global task force to provide oxygen, medicines and supplies on a war footing to India. Also, a “strike team” of experts from the Centre for Disease Control (CDC) is being deployed to help combat the Indian pandemic.
Covid 19: Empty middle seats cuts risk on planes says CDC study nzherald.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nzherald.co.nz Daily Mail and Mail on Sunday newspapers.
Sinopharm vaccine in UAE: how effective is it against Covid-19 and are there side effects?
In recent weeks we ve learned much more about the vaccine s efficacy, ability to fight new strains and how long protection lasts for
Abu Dhabi resident Abdulaziz Karmastaji gets vaccinated at Seha s cruise ship terminal facility in January
Abu Dhabi resident Shaikha Al Dheiri waiting to get vaccinated.
A healthcare worker smiles for the cameras.
Nearly 20,000 people are vaccinated daily at the centre.
Mohamed Hawas Al Sadid, chief executive of Seha, said nearly 20,000 people are getting shots every day.
People in the waiting room.
An Emirati waits for her turn to get the vaccine.
TATA, CSIR in talks with Moderna to conduct trials, bring COVID-19 vaccine to India
Moderna s vaccine is based on mRNA technology and it 94 percent effective at preventing COVID-19 in people who were given two doses and had no history of the infection.
Feb 01, 2021 11:48:39 IST
TATA Group s newly launched medical venture Tata Medical & Diagnostics is reportedly in talks with Moderna to bring its COVID-19 vaccine to India after conducting clinical trials to ensure its safety and efficacy.
The Economic Times reported that the dialogue is still in its early days and that sources have said that the company would partner up with the Council of Scientific & Industrial Research (CSIR) to carry out the necessary clinical trials of Moderna’s vaccine candidate in India.